Clear Harbor Asset Management LLC reduced its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 32.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 6,003 shares of the company’s stock after selling 2,948 shares during the quarter. Clear Harbor Asset Management LLC’s holdings in GE HealthCare Technologies were worth $469,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds also recently added to or reduced their stakes in the stock. Quent Capital LLC grew its holdings in shares of GE HealthCare Technologies by 18.4% in the 3rd quarter. Quent Capital LLC now owns 766 shares of the company’s stock worth $72,000 after acquiring an additional 119 shares during the period. Greenleaf Trust increased its position in shares of GE HealthCare Technologies by 1.7% in the third quarter. Greenleaf Trust now owns 7,619 shares of the company’s stock valued at $715,000 after buying an additional 124 shares in the last quarter. Westside Investment Management Inc. raised its stake in shares of GE HealthCare Technologies by 32.0% during the 3rd quarter. Westside Investment Management Inc. now owns 516 shares of the company’s stock worth $48,000 after buying an additional 125 shares during the last quarter. EverSource Wealth Advisors LLC boosted its position in shares of GE HealthCare Technologies by 8.7% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,590 shares of the company’s stock worth $135,000 after buying an additional 127 shares in the last quarter. Finally, Quarry LP grew its stake in GE HealthCare Technologies by 28.3% in the 2nd quarter. Quarry LP now owns 594 shares of the company’s stock valued at $46,000 after acquiring an additional 131 shares during the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.
GE HealthCare Technologies Price Performance
GEHC opened at $87.34 on Wednesday. GE HealthCare Technologies Inc. has a 1 year low of $71.31 and a 1 year high of $94.55. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23. The company’s 50 day simple moving average is $82.02 and its 200 day simple moving average is $84.56. The stock has a market capitalization of $39.90 billion, a PE ratio of 23.99, a P/E/G ratio of 2.80 and a beta of 1.11.
GE HealthCare Technologies Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.16%. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date of this dividend is Tuesday, January 14th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.85%.
Insider Activity
In related news, CEO Roland Rott sold 3,577 shares of GE HealthCare Technologies stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total transaction of $309,338.96. Following the transaction, the chief executive officer now owns 24,298 shares in the company, valued at approximately $2,101,291.04. The trade was a 12.83 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 0.27% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities analysts have issued reports on the stock. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their target price for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. UBS Group downgraded GE HealthCare Technologies from a “neutral” rating to a “sell” rating and cut their price objective for the stock from $84.00 to $74.00 in a research report on Thursday, September 26th. Stifel Nicolaus increased their target price on GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a report on Monday, September 30th. Wells Fargo & Company boosted their price target on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a report on Thursday, October 31st. Finally, Evercore ISI increased their price objective on GE HealthCare Technologies from $98.00 to $102.00 and gave the company an “outperform” rating in a research note on Tuesday, October 1st. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $96.00.
View Our Latest Stock Analysis on GEHC
GE HealthCare Technologies Company Profile
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Recommended Stories
- Five stocks we like better than GE HealthCare Technologies
- Trading Stocks: RSI and Why it’s Useful
- SAP’s Strong Momentum: A Bullish Setup for Investors
- 3 Stocks to Consider Buying in October
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- Want to Profit on the Downtrend? Downtrends, Explained.
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.